University of Miami reports positive Phase II trial result of arimoclomol to treat ALS

University of Miami Miller School of Medicine has reported positive data from its Phase II trial of arimoclomol to treat amyotrophic lateral sclerosis (ALS).

Source: Drug Development Technology - December 13, 2016 Category: Pharmaceuticals Source Type: news